Market Cap

N4 Pharma plc Market Capitalization:

£4.4 Million

GBP as of Jan. 1, 2026

US$5.9 Million

business N4 Pharma plc Company Profile

N4 Pharma plc Main Stock Listing

LSE: N4P

Market Capitalization History of N4 Pharma plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of N4 Pharma plc market cap

Date Market Cap YoY Change
Jan. 1, 2026 £4.4 M 58.12%
Jan. 1, 2025 £2.8 M -17.75%
Jan. 1, 2024 £3.4 M -28.14%
Jan. 1, 2023 £4.7 M -42.45%
Jan. 1, 2022 £8.1 M -55.16%
Jan. 1, 2021 £18.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

N4 Pharma plc Categories

United Kingdom languages Healthcare languages Drug Manufacturers—Specialty & Generic
United Kingdom Healthcare United Kingdom Drug Manufacturers—Specialty & Generic

Stocks & Indices

N4 Pharma plc has the following listings and related stock indices.


Stock: LSE: N4P

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.